SCHEMBL7701724

SCHEMBL7701724

O=C(NCc1ccc(S(=O)(=O)N2CC[C@@H](O)C2)s1)c1ccc(Cl)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK9 P45984 1/20 0.62
MAPK10 P53779 1/20 0.62
MEN1 O00255 2/20 0.55
KMT2A Q03164 2/20 0.55
BCL2 P10415 1/20 0.44
BCL2L1 Q07817 1/20 0.44
EPHX2 P34913 1/20 0.44
USP5 P45974 1/20 0.44
ALDH1A1 P00352 5/20 0.43
POLB P06746 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.42
TP53 P04637 1/20 0.42
MAPT P10636 1/20 0.42
LMNA P02545 3/20 0.42
KDM4E B2RXH2 1/20 0.42
HTT P42858 1/20 0.42
CYP3A4 P08684 1/20 0.41
RECQL P46063 1/20 0.41
PKM P14618 1/20 0.41
TSHR P16473 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2426655 0.94 MAPK9 (0.66) MAPK9MAPK10MEN1KMT2ABCL2
SCHEMBL2426036 0.86 MAPK9 (0.64) MAPK9MAPK10MEN1KMT2ABCL2
SCHEMBL1518918 0.84 MAPK9 (0.62) MAPK9MAPK10MEN1KMT2ABCL2
SCHEMBL6437014 0.84 MAPK9 (0.65) MAPK9MAPK10MEN1KMT2ABCL2
SCHEMBL2428799 0.84 MAPK9 (0.61) MAPK9MAPK10MEN1KMT2AALDH1A1
SCHEMBL3479911 0.82 MAPK9 (0.55) MAPK9MAPK10MEN1KMT2ABCL2
SCHEMBL2423811 0.82 MEN1 (0.68) MAPK9MAPK10MEN1KMT2ABCL2
SCHEMBL2420008 0.82 MAPK9 (0.68) MAPK9MAPK10MEN1KMT2ABCL2
SCHEMBL2422442 0.82 MAPK9 (0.65) MAPK9MAPK10MEN1KMT2ABCL2
SCHEMBL2425870 0.82 MAPK9 (0.60) MAPK9MAPK10MEN1KMT2ABCL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1322642-B1 Pharmaceutically active sulfonamide derivatives bearing both lipophilic and ionisable moieties as inhibitors of Protein Jun-kinases MERCK SERONO SA (CH) 2013-09-04 EP disclosed
EP-1193268-A1 Pharmaceutically active sulfonamide derivatives bearing both lipophilic and ionisable moieties as inhibitors of protein Junkinases Applied Research Systems ARS Holding N.V. (AN) 2002-04-03 EP disclosed